Hitachi receives FDA 510(k) for advanced motion management for its proton therapy system

(Hokkaido University) Hitachi, Ltd. and Hokkaido University announced that it has obtained U.S. Food& Drug Administration (FDA) 510(k) clearance for the commercialization of " Real Time Image Gating System for Proton Beam Therapy Systems " (RGPT), allowing for its systems in the United States to treat patients with cutting-edge motion management together with its advanced Spot Scanning irradiation technology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news